Novavax (NVAX) EBIT Growth (3y) (2013 - 2026)
Novavax (NVAX) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
16.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-50.81% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
63.32% |
| Date | Value |
|---|
| Mar 31, 2026 |
63.32% |
| Dec 31, 2025 |
27.21% |
| Sep 30, 2025 |
-11.86% |
| Jun 30, 2025 |
30.24% |
| Mar 31, 2025 |
35.05% |
| Dec 31, 2024 |
45.84% |
| Sep 30, 2024 |
24.15% |
| Jun 30, 2024 |
35.09% |
| Mar 31, 2024 |
11.46% |
| Dec 31, 2023 |
-0.13% |
| Sep 30, 2023 |
13.47% |
| Jun 30, 2023 |
73.88% |
| Mar 31, 2023 |
-139.05% |
| Dec 31, 2022 |
-104.05% |
| Sep 30, 2022 |
-103.98% |
| Jun 30, 2022 |
-136.17% |
| Mar 31, 2022 |
93.13% |
| Dec 31, 2021 |
-160.79% |
| Sep 30, 2021 |
-94.26% |
| Jun 30, 2021 |
-101.94% |
